Baxter International (BAX)

R&D Expense Growth

-7.19%

Quarterly · Period ending:

BAX logo

BAX R&D Expense Growth

Latest reported-7.19%
BAX Quarterly R&D Growth (QoQ) (0.00% → -7.19%)
High-resolution chart · PNG

BAX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Baxter International R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
0.9709%
-2.8302%
9.2784%
4.3011%
12.0482%
-7.7778%
8.4337%
-1.1905%
12%
-18.4783%
3.3708%
5.9524%
-2.3256%
-21.8182%
13.4021%
2.1053%
5.5556%
0%
7.1429%
0%
2.439%
-1.2048%
-17%
19.0476%
7.6923%
-17.8947%
7.9545%
4.7619%
10.5263%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.